Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on May 24, 2023 12:54pm
176 Views
Post# 35462160

RE:FDA in <2weeks?

RE:FDA in <2weeks?Your math is correct assuming the company filed the new protocol in the first few days of May as we suspect they did. But the exact date has never been disclosed. We all know that the trial being restarted is a big deal for the stock's potential but it is not likely to get too much traction since so few seem to be paying attention to the stock right now. The company's planned investor call on the restarted trial should help but I don't see any analysts raising their price targets on the news of the restarted trial or as a result of the investor call. My best guess is the stock gets a smallish pop on this news as investors wait for hard news of success int he restarted trial before really jumping on board. Also, if they sign an intriguing partnership deal or two, that would help validate TH-1902 in investor eyes and could send the stock meaningfully higher.  I think we are safer assuming a partner wants to see good data too before agreeing to partner with THTX on TH-1902. Hopefully, that  AACR presentation  will accelrate partnership deals but I am not betting on it.

We voted in favor of all the directors in order to give the Chairwoman flexiility, if she wanted it, in determining how to reduce the board size to save money as well as to give the two board members who recieved the fewest votes the opportunity to leave the board without technically getting fired by shareholders. I too am disappointed we have not seen any announcements about that yet but perhaps THTX will bundle a number of announcements together for maximum impact?  Hopefully, that is the case. Paul spoke of "decisive action and agile tactics" at the AGM so I think we are all hopeful we will see a demonstration of that very soon.
Kd5513 wrote:
We should have FDA response in less than 2 weeks if my math is correct.

It would be nice if leading up to this there was announcement of 2 board members have resigned and possible replacement with one high octane individual from US to back fill both. I'm a little irritated at this point it hasnt happened. How they could think they deserve a seat with the vote that just took place is mind boggling.


<< Previous
Bullboard Posts
Next >>